FOXO TECHNOLOGIES INC. Derivative Liability, Noncurrent
FOXO TECHNOLOGIES INC. (FOXO) had Derivative Liability, Noncurrent of $496 as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-04-15
- 2025-09-30: Derivative Liability, Noncurrent $496.00.
- 2025-06-30: Derivative Liability, Noncurrent $2.08K.
- 2025-03-31: Derivative Liability, Noncurrent $9.65K.
- 2024-12-31: Derivative Liability, Noncurrent $41.25K.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2025-09-30 | $496.00 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.08K 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $9.65K 10-Q/A · filed 2025-08-19 | |
| 2024-12-31 | $41.25K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $7.00K 10-Q · filed 2024-11-19 | |
| 2023-12-31 | $8.82K 10-K · filed 2025-04-15 | $8.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |